Chairman of the Research and Development and Production Committee
Dr. Michael Rosenblatt joined the Ferring Board of Directors in July 2024 as Chairman of the Research and Development and Production Committee. He was formerly Chief Medical Officer at Merck & Co., Inc, a Professor of Medicine at Harvard Medical School, and Dean of Tufts University School of Medicine. Before joining Ferring, Dr. Rosenblatt was Chief Medical Officer of the life sciences venture capital company Flagship Pioneering, and served as Director of several of its portfolio companies. During his career, he has also held senior scientific and management roles at a number of biopharmaceutical companies. Dr. Rosenblatt gained his M.D. magna cum laude degree from Harvard University in the U.S.
